Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
How Long Will I Need to Be on GLP-1 Therapy
To view or add a comment, sign in Researchers found that follistatin (FST) protects against atherosclerosis by increasing fat burning, improving mitochondrial function, reducing inflammation, stabilizing arterial plaques, and enhancing lipid metabolism, making it a promising therapeutic target for cardiovascular disease
Alembic Pharmaceuticals Limited Boehringer Ingelheim Sources Primary Research Interviews: Endocrinologists and diabetologists Pharmacy benefit manager (PBM) formulary leads Brand and medical affairs at GLP-1 / DPP-4 manufacturers Diabetes educators Databases: IQVIA MIDAS Symphony Health PHAST Evaluate Pharma Citeline (Trialtrove) Magazines: Pharmaceutical Executive FiercePharma Endocrine News Diabetes Self-Management Journals: The Lancet Diabetes & Endocrinology Diabetes Care (ADA) Diabetologia (EASD) The New England Journal of Medicine Newspapers: The Wall Street Journal Financial Times Reuters The New York Times Associations: American Diabetes Association (ADA) European Association for the Study of Diabetes (EASD) International Diabetes Federation (IDF) Endocrine Society Public Domain Sources: U.S
,
